Saturday 17 October 2026
Export KAPA’s income statement to Excel — free account
Kairos Pharma, Ltd.
KAPA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 25.0% and free cash flow fell 25.7%, each against the same quarter a year earlier.
0.60
0.07
−10.45%
Follow KAPA
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
0.27 | 0.04 | 4.20 | 27.07 |
Net Debt/EBITDA |
(49.67) | (0.37) | 2.04 | 1.65 |
Debt/Assets |
56.56% | 66.53% | 0.00% | 0.00% |
Debt/Equity |
(0.50) | (0.31) | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.34 | (0.04) | 1.52 | 0.63 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(11.20) | (40.81) | (66.94) | — |
| 0.00% | 111.27% | (192.96%) | (97.99%) | |
| 0.00% | (181.11%) | (77.32%) | (88.51%) | |
ROIC |
0.00% | 0.00% | (227.03%) | (346.52%) |
Return on Tangible Assets |
87.79% | 78.65% | (81.93%) | (104.99%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.52 | 0.40 | 0.04 | 0.01 |
Share Based Compensation of Revenue |
— | — | 0.00% | — |
Free Cash Flow per Share |
(0.23) | 0.05 | (2.44) | (1.31) |
Cash per Share |
0.28 | 0.06 | 2.55 | 2.03 |
Shareholders Equity per Share |
(0.76) | (1.40) | 2.94 | 2.41 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.76) | (1.40) | 2.94 | 2.41 |
Free Cash Flow |
(0.35) | 0.08 | (3.95) | (3.44) |
Working Capital |
(1.20) | (2.30) | 3.18 | 5.19 |
Net Current Asset Value |
(1.78) | (2.94) | 3.18 | 5.19 |
| Other line items | ||||
Quick Ratio |
0.27 | 0.04 | 4.16 | 26.81 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
226.28% | (6.03%) | (44.40%) | (29.47%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.23) | 0.05 | (2.44) | (1.31) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
— | 2.02 | 1.70 | 0.60 |
Average Assets |
— | 1.00 | 3.37 | 6.15 |
Average Common Equity |
— | (1.63) | 1.35 | 5.56 |
Columns are period end dates